No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Gouty / drug therapy*
-
Arthritis, Gouty / immunology
-
Caspase Inhibitors / therapeutic use
-
Evidence-Based Medicine
-
Humans
-
Inflammation / drug therapy
-
Randomized Controlled Trials as Topic
-
Rheumatology* / trends
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
alpha 1-Antitrypsin / therapeutic use*
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Caspase Inhibitors
-
Tumor Necrosis Factor-alpha
-
alpha 1-Antitrypsin
-
canakinumab
-
brodalumab
-
secukinumab